It is important to note that none of those pathways are regulated solely by the TGF-β family, but act as downstream effectors of numerous pro-PAH agonists, including growth factors that signal through receptor tyrosine kinases (RTK) [6]. This evidence concerns the gene NTRK1 and pulmonary arterial hypertension.